.

ISSN 2063-5346
For urgent queries please contact : +918130348310

ECONOMIC BURDEN OF COVID19; A COST ILLNESS STUDY IN TERTIARY CARE HOSPITAL

Main Article Content

Swathi Sree Vasantha, Varagani Srinivasa Rao, Annavarapu Vamsi Krishna Chanukya, Dr. B. Satish Kumar, Dr. Venkata Rama Rao Nallani, Ramarao Nadendla, DR. K. Sandeep
ยป doi: 10.31838/ecb/2023.12.s3.704

Abstract

The COVID 19 is an infectious disease caused by the SARS-COV-2 Virus. Patient characteristics, clinical outcomes, and resource use of hospitalized COVID-19 patients have been described. However, limited data are available describing the direct healthcare costs associated with hospital resource utilization among hospitalized COVID-19 patients. Therefore, economic models of the impact of COVID-19. Specific data describing the healthcare costs of hospitalized COVID-19 patients are needed to fully understand the economic burden of COVID-19 and to aid decision makers as they plan future investments in COVID-19 prevention and treatment strategies. The main aim of study was to assess the total estimated health-care costs associated with COVID-19. It is a Retrospective data analysis study was conducted in Government General Hospital, Guntur for a span of 6 months (September 2021 โ€“ February 2022) after obtaining ethical committee approval. The economic burden of covid 19 was assessed based on the treatment provided and medication cost of government.161 Patients Who met the inclusion criteria were included in the study. The data obtained was tabulated and analysed using advanced Microsoft excel and found the median hospital length of stay was 12 days, median hospital charges were 4500. On an average a patients costs of 450 rs to 500 rs a day.Our study findings provide a comprehensive profile of hospitalized COVID-19 patients offer valuable insights into the patient health outcomes and the hospital economic burden of COVID-19 in the INDIA stratified by disease progression state, age groups, and medication cost. Further studies are warranted in both inpatient and outpatient settings, especially with longer study time frames and further stratifications (e.g., by other patient demographics and clinical characteristics), in addition to studies on the evaluation of treatment patterns and continuum of care, to provide an accurate understanding of the health outcomes and healthcare economic burden of patients with COVID-19 in their entirety.

Article Details